PT  - JOURNAL ARTICLE
ED  - Feldman, Ted
TI  - EVEREST Trial 2-Year Results Show Stability of Percutaneous MV Repair between Years 1 and 2
DP  - 2011 Jun 01
TA  - MD Conference Express
PG  - 17--18
VI  - 11
IP  - 3
4099  - http://mdc.sagepub.com/content/11/3/17.short
4100  - http://mdc.sagepub.com/content/11/3/17.full
AB  - The 2-year results from the Endovascular Valve Edge-to-Edge Repair trial [EVEREST II; NCT00209274] showed that percutaneous mitral valve repair is safe and durable with measurable clinical benefits and is a therapeutic option for select patients with significant mitral regurgitation [Feldman T et al. N Engl J Med 2011].